Development
Dolby Laboratories, Inc.
DLB
$71.98
-$0.36-0.50%
NYSE
| 12/29/2023 | 09/29/2023 | 06/30/2023 | 03/31/2023 | 12/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 66.98M | 9.19M | 16.40M | 95.70M | 79.38M |
| Total Depreciation and Amortization | 20.96M | 24.26M | 24.30M | 24.59M | 22.36M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.36M | 46.28M | 31.30M | 16.69M | 18.64M |
| Change in Net Operating Assets | -101.89M | 5.29M | 49.13M | -32.43M | -63.98M |
| Cash from Operations | 8.41M | 85.02M | 121.13M | 104.54M | 56.40M |
| Capital Expenditure | -6.10M | -8.19M | -7.41M | -7.52M | -7.22M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 25.70M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.73M | -11.53M | 3.74M | 31.11M | 35.52M |
| Cash from Investing | 633.00K | -19.71M | 22.03M | 23.59M | 28.30M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 19.02M | 10.55M | 15.84M | 10.44M | 10.95M |
| Repurchase of Common Stock | -114.56M | -27.53M | -26.82M | -51.66M | -74.41M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -28.55M | -25.82M | -25.84M | -25.87M | -25.87M |
| Other Financing Activities | -1.05M | 0.00 | 0.00 | 0.00 | -766.00K |
| Cash from Financing | -125.14M | -42.80M | -36.83M | -67.10M | -90.09M |
| Foreign Exchange rate Adjustments | 6.79M | -3.70M | -596.00K | 911.00K | 8.50M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -109.31M | 18.81M | 105.74M | 61.94M | 3.11M |